Medical Writing. Joaquín Rodrigo, CEO of Sandoz and president of Biosim, is clear: biosimlars are a fundamental tool for future sustainability. Of course, for its survival over time, it considers a specific regulatory framework essential to facilitate its development and penetration. Likewise, he hopes that these products do not have to face the same obstacles as generics for their commercialization: "I believe that past mistakes can be learned."

READ MORE